T/TPPA 0002-2022 Active Group standards

T/TPPA 0002-2022 RBL-2H3 mast cell RTCA method for evaluating allergy reactions of traditional Chinese medicine injection operation procedures

Publish Date: 2022-12-22 Implement Date: 2022-12-22 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Download

Basic Information

Standard Code: T/TPPA 0002-2022

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: -

ICS Name: Comprehensive Pharmaceutical Science

Publish Date: 2022-12-22

Implement Date: 2022-12-22

Pages: 6 pages

Scope

Main technical content: This standard specifies the method of evaluating allergic reactions to traditional Chinese medicine injections using RBL-2H3 mast cells RTCA, and provides a detailed description of the corresponding method. This standard includes the reagents, instruments, cells, cell culture solutions, and other materials required for the experiment, as well as the preparation of reagents and other operational steps. The research content of this standard includes the detection principle of the method, cell culture, subculture, cryopreservation and resuscitation, and the specific operation steps of RTCA detection. Statistical analysis software is used to analyze the experimental data, and the experimental data are expressed as mean ± s. When comparing the experimental groups with the negative control group, P < 0.05 indicates a significant difference, indicating a potential risk of allergic reactions.